Evidence map›Paper›PMID 26272061›Full record

ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2016

The results of two-stage revision TKA using Ceftazidime-Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections.

Michael Drexler, Tim Dwyer, Paul R T Kuzyk, Yona Kosashvilli, Mansour Abolghasemian, Gilad J Regev, Assaf Kadar, Tal Frenkel Rutenberg, David Backstein

Abstract read
PubMed Publisher
In one paragraph

Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Handmade articulating spacer for two-stage exchange at the knee.Operative Orthopadie und Traumatologie · 2023
    Review
  6. Article
  7. Article
  8. Periprosthetic Knee Infection - Part 2: Treatment.Revista brasileira de ortopedia · 2022
    Article
  9. Article
  10. Article
  11. Articulated spacer provides long-term knee improvement after two-stage reimplantation.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2016
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Michael DrexlerMount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. mt.drexler@gmail.com.
Tim DwyerMount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Paul R T KuzykMount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Yona KosashvilliMount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Mansour AbolghasemianMount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Gilad J RegevTel-Aviv Sourasky Medical Center, Tel Aviv University, Waitzman 6 St, 6423906, Tel Aviv, Israel.
Assaf KadarTel-Aviv Sourasky Medical Center, Tel Aviv University, Waitzman 6 St, 6423906, Tel Aviv, Israel.
Tal Frenkel RutenbergTel-Aviv Sourasky Medical Center, Tel Aviv University, Waitzman 6 St, 6423906, Tel Aviv, Israel.
David BacksteinMount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Mount Sinai Hospital · CATel Aviv Sourasky Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study examined the success and factors associated with failure, of using cement spacers impregnated with high-dose Ceftazidime and Vancomycin when performing two-stage revision for infected total knee arthroplasty (TKA).

methodsA retrospective analysis was performed using a prospectively collected database of 82 patients (median age 68 years, range 39-87) with a confirmed deep TKA infection treated with a two-stage revision. All cement spacers were impregnated with high-dose Ceftazidime and Vancomycin. The rate of success was recorded-an association between failure of treatment, and patient factors, previous surgical treatment, and microbial characteristics was sought.

resultsThe mean time to infection from index arthroplasty was 45 months (range 3-240). The initial two-stage revision was successful in 70/82 patients (85.4 %), who remained free of infection at average follow-up of 36.2 months (range 24-85). A second two-stage revision for infection was required in 12/82 patients (14.6 %), which was successful in 4/12 (33 %). A third two-stage revision was performed in three patients, all of whom had a polymicrobial infection of which only one patient had successful eradication of infection. Recurrent infection was correlated with irrigation and debridement with implant retention prior to initial two-stage revision (p < 0.01), polymicrobial infections (p = 0.035), and infections presenting <6 months after index surgery (p = 0.031). No correlation was seen with age, BMI, type of organism, diabetes mellitus, or Charlson Comorbidity Index.

conclusionThe findings of this study suggest that the combination of Ceftazidime and Vancomycin in cement spacers is as efficacious as other published single or combined antibiotic mixtures, which is clinically relevant to clinicians treating this difficult problem in the setting of patients with compromised renal function.

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsArthroplasty, Replacement, KneeBone CementsCeftazidimeFemaleHumansKnee ProsthesisMaleMiddle AgedProsthesis-Related InfectionsReoperationRetrospective StudiesVancomycinAnti-Bacterial AgentsBone CementsCeftazidimeVancomycinCeftazidime–VancomycinImpregnated cement spacersTwo-stage revision TKA

Identifiers

PMID26272061
OpenAlexW1132926317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.